Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.00023 | 1 |